Description: We develop state-of-the-art biomedical instrumentation for translational and clinical research. These range from portable, hybrid systems that combine diffuse correlation spectroscopy (DCS) with near-infrared diffuse optical spectroscopy (NIRS-DOS) to laser speckle based animal images. We have industrial, biomedical and clinical relationships that drive the specifications of these systems. Recently, we have also undertaken a large-scale project to develop prototypes that are clinically and commercially viable. We are working to implement state-of-the-art digital electronics, new light sources and detectors as well as novel fiber optics. Part of this technology was commercialized by ICFO spin-off company Hemophotonics, SL led by Dr Udo Weigel.
Project Status: ongoing
